Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.33 |
| ▸ | FAP | Q12884 | 1/20 | 0.33 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | LAP3 | P28838 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9235726 | 1.00 | SLC7A5 (0.44) | SLC7A5DPP4SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL8401187 | 0.98 | SLC7A5 (0.42) | SLC7A5DPP4SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL8401189 | 0.98 | SLC7A5 (0.42) | SLC7A5DPP4SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL17912256 | 0.83 | SLC7A5 (0.38) | SLC7A5 | |
| SCHEMBL16540478 | 0.83 | SLC7A5 (0.38) | SLC7A5 | |
| SCHEMBL17912255 | 0.83 | SLC7A5 (0.38) | SLC7A5 | |
| SCHEMBL13984761 | 0.80 | SLC1A3 (0.39) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL10453588 | 0.80 | SLC1A3 (0.31) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL8404068 | 0.80 | SLC1A3 (0.31) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL9112299 | 0.80 | SLC1A3 (0.31) | SLC7A5SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3039068-B1 | MOISTURE CURABLE COMPOUND WITH AMINO ACIDS | MOMENTIVE PERFORMANCE MAT INC (US) | 2020-12-16 | — | — | EP | claimed |
| US-20160200880-A1 | MOISTURE CURABLE COMPOSITION WITH AMINO ACIDS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2016-07-14 | — | — | US | claimed |
| EP-3039068-A1 | MOISTURE CURABLE COMPOUND WITH AMINO ACIDS | Momentive Performance Materials Inc. (US) | 2016-07-06 | — | — | EP | claimed |
| WO-2015031712-A1 | MOISTURE CURABLE COMPOUND WITH AMINO ACIDS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2015-03-05 | — | — | WO | claimed |
| EP-0636117-A4 | METHOD OF ADMINISTERING PYRUVATE AND METHODS OF SYNTHESIZING PYRUVATE PRECURSORS. | ABBOTT LAB (US) | 1995-07-26 | — | — | EP | claimed |
| EP-0636117-A1 | USE OF PYRUVAMIDE AND SELECTED PYRUVYL-AMINO ACIDS | ABBOTT LABORATORIES (US) | 1995-02-01 | — | — | EP | claimed |
| WO-1993021147-A1 | METHOD OF ADMINISTERING PYRUVATE AND METHODS OF SYNTHESIZING PYRUVATE PRECURSORS | ABBOTT LABORATORIES (US) | 1993-10-28 | — | — | WO | claimed |
| EP-3039068-B1 | MOISTURE CURABLE COMPOUND WITH AMINO ACIDS | MOMENTIVE PERFORMANCE MAT INC (US) | 2020-12-16 | — | — | EP | disclosed |
| US-9914809-B2 | Moisture curable composition with amino acids | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2018-03-13 | — | — | US | disclosed |
| US-20160200880-A1 | MOISTURE CURABLE COMPOSITION WITH AMINO ACIDS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2016-07-14 | — | — | US | disclosed |
| EP-3039068-A1 | MOISTURE CURABLE COMPOUND WITH AMINO ACIDS | Momentive Performance Materials Inc. (US) | 2016-07-06 | — | — | EP | disclosed |
| WO-2015031712-A1 | MOISTURE CURABLE COMPOUND WITH AMINO ACIDS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2015-03-05 | — | — | WO | disclosed |
| EP-0636117-B1 | USE OF PYRUVAMIDE AND SELECTED PYRUVYL-AMINO ACIDS | STANKO RONALD T (US) | 1999-06-23 | — | — | EP | disclosed |
| US-5472980-A | Reducing insulin resistance in mammals with amino acid derivatives | ABBOTT LABORATORIES (US) | 1995-12-05 | — | — | US | disclosed |
| US-5312985-A | Reaction of sodium pyruvate with thionyl chloride and oxalyl chloride to form pyruvyl chloride, then reaction with 1,1,1,3,3,3-hexamethyldisilazane and methanol to form pyruvamide | ABBOTT LABORATORIES (US) | 1994-05-17 | — | — | US | disclosed |
| US-5283260-A | Oral ingesting a pyruvyl-amino acid compound before a glucose tolerance test | ABBOTT LABORATORIES (US) | 1994-02-01 | — | — | US | disclosed |
| US-5256697-A | Covalently linked pyruvyl-amino compound | ABBOTT LABORATORIES | 1993-10-26 | — | — | US | disclosed |